| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6004996 | CHEPLAPHARM | Tetrahydrolipstatin containing compositions |
Jan, 2018
(6 years ago) | |
|
US6004996 (Pediatric) | CHEPLAPHARM | Tetrahydrolipstatin containing compositions |
Jul, 2018
(5 years ago) | |
Xenical is owned by Cheplapharm.
Xenical contains Orlistat.
Xenical has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Xenical are:
- US6004996
- US6004996*PED
Xenical was authorised for market use on 23 April, 1999.
Xenical is available in capsule;oral dosage forms.
The generics of Xenical are possible to be released after 06 July, 2018.
Drugs and Companies using ORLISTAT ingredient
Market Authorisation Date: 23 April, 1999
Treatment: NA
Dosage: CAPSULE;ORAL
More Information on Dosage
XENICAL family patents
